Anavex Life Sciences

Anavex Life Sciences to Showcase at BTIG Virtual Biotechnology Conference 2023

(GLOBE NEWSWIRE) — NEW YORK, Aug. 2, 2023 — Anavex Life Sciences Corp. (“Anavex” or “the Company”) AVXL, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders like Alzheimer’s disease, Parkinson’s disease, Rett syndrome, and other central nervous system (CNS) disorders, announced today that Christopher U. Missling, PhD, President […]

Anavex Life Sciences to Showcase at BTIG Virtual Biotechnology Conference 2023 Read More ยป